Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Torsten Dreier | Researchclopedia

Back to researchers

Torsten Dreier

Medical University of Vienna

68

Works

3,674

Citations

23

h-index

33

i10-index

Research Topics

Monoclonal and Polyclonal Antibodies Research Liver physiology and pathology CAR-T cell therapy research

Affiliations

Scripps Research Institute1998–1998

Ablynx (Belgium)2006–2021

University of Vienna2025–2025

Institut Jules Bordet2016–2016

Fujifilm (Japan)1998–1998

Top Works

Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody

Torsten Dreier,Grit Lorenczewski,et al.

2002351 citations

Glycosylation and Glycoproteins Research

Platelet Disorders and Treatments

Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans

Peter Ulrichts,Antonio Guglietta,et al.

2018348 citations

Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis

Ken Coppieters,Torsten Dreier,et al.

2006298 citations

Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

Bernard M. Tijink,Toon Laeremans,et al.

2008291 citations

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Klaas Vandenbroucke,Hans de Haard,et al.

2009283 citations

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

James F. Howard,Vera Bril,et al.

2019276 citations

T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct

Torsten Dreier,Patrick A. Baeuerle,et al.

2003194 citations

Natural Killer Cell–Mediated Eradication of Neuroblastoma Metastases to Bone Marrow by Targeted Interleukin-2 Therapy

Holger N. Lode,Rong Xiang,et al.

1998178 citations

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

Adrian C. Newland,Blanca Sánchez‐González,et al.

2019176 citations